R. A. Clare

776 total citations
17 papers, 606 citations indexed

About

R. A. Clare is a scholar working on Clinical Biochemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, R. A. Clare has authored 17 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Clinical Biochemistry, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in R. A. Clare's work include Metabolism and Genetic Disorders (5 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Inflammatory mediators and NSAID effects (3 papers). R. A. Clare is often cited by papers focused on Metabolism and Genetic Disorders (5 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Inflammatory mediators and NSAID effects (3 papers). R. A. Clare collaborates with scholars based in United Kingdom. R. A. Clare's co-authors include G. H. Draffan, C. T. Dollery, Sandra Murray, D. S. Davies, Mira Doig, Caron Dean, John L. Reid, H. J. Dargie, Thomas A. Baillie and Ian A. Blair and has published in prestigious journals such as Journal of Chromatography A, Thorax and Clinical Pharmacology & Therapeutics.

In The Last Decade

R. A. Clare

17 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. A. Clare United Kingdom 10 143 102 97 88 84 17 606
Emil R. Smith United States 16 211 1.5× 59 0.6× 113 1.2× 133 1.5× 42 0.5× 45 840
P. A. Toseland United Kingdom 19 174 1.2× 116 1.1× 80 0.8× 92 1.0× 246 2.9× 66 1.1k
A. Hayes United Kingdom 8 162 1.1× 50 0.5× 56 0.6× 133 1.5× 33 0.4× 15 599
Samuel A. Cucinell United States 15 154 1.1× 70 0.7× 56 0.6× 142 1.6× 185 2.2× 33 1.1k
Jürgen H. Hengstmann Germany 15 110 0.8× 62 0.6× 154 1.6× 159 1.8× 54 0.6× 35 743
Denis Lamiable France 16 125 0.9× 97 1.0× 48 0.5× 168 1.9× 74 0.9× 73 770
C.J. van Boxtel Netherlands 20 98 0.7× 72 0.7× 42 0.4× 84 1.0× 96 1.1× 47 893
M. G. Bogaert Belgium 16 88 0.6× 56 0.5× 52 0.5× 153 1.7× 26 0.3× 34 533
Robert A. Ronfeld United States 18 147 1.0× 85 0.8× 139 1.4× 236 2.7× 148 1.8× 29 1.0k
Patrick K. Noonan United States 20 86 0.6× 28 0.3× 75 0.8× 105 1.2× 74 0.9× 40 901

Countries citing papers authored by R. A. Clare

Since Specialization
Citations

This map shows the geographic impact of R. A. Clare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. A. Clare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. A. Clare more than expected).

Fields of papers citing papers by R. A. Clare

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. A. Clare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. A. Clare. The network helps show where R. A. Clare may publish in the future.

Co-authorship network of co-authors of R. A. Clare

This figure shows the co-authorship network connecting the top 25 collaborators of R. A. Clare. A scholar is included among the top collaborators of R. A. Clare based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. A. Clare. R. A. Clare is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ayrton, John, R. A. Clare, Gordon J. Dear, David N. Mallett, & Robert S. Plumb. (1999). Ultra-high flow rate capillary liquid chromatography with mass spectrometric detection for the direct analysis of pharmaceuticals in plasma at sub-nanogram per millilitre concentrations. Rapid Communications in Mass Spectrometry. 13(16). 1657–1662. 34 indexed citations
2.
Schwartz, S., et al.. (1997). Pharmacokinetics, disposition and metabolism of 546C88 (L-NG-methylarginine hydrochloride) in rat and dog. Xenobiotica. 27(12). 1259–1272. 9 indexed citations
4.
Doig, Mira & R. A. Clare. (1991). Use of thermospray liquid chromatography-mass spectrometry to aid in the identification of urinary metabolites of a novel antiepileptic drug, Lamotrigine. Journal of Chromatography A. 554(1-2). 181–189. 56 indexed citations
5.
Clare, R. A., Shuigen Huang, Mira Doig, & G. Gordon Gibson. (1991). Gas chromatographic—mass spectrometric characterisation of some novel hydroxyeicosatetraenoic acids formed on incubation of arachidonic acid with microsomes from induced rat livers. Journal of Chromatography B Biomedical Sciences and Applications. 562(1-2). 237–247. 16 indexed citations
6.
Blair, Ian A., Roberto Tinoco, Martin J. Brodie, et al.. (1985). Plasma Hydrazine Concentrations in Man after Isoniazid and Hydralazine Administration. Human Toxicology. 4(2). 195–202. 80 indexed citations
7.
Gibbons, G F, Clive R. Pullinger, Thomas A. Baillie, & R. A. Clare. (1980). Metabolism of hydroxy sterols by rat liver. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 619(1). 98–106. 5 indexed citations
8.
Clare, R. A., Donald S. Davies, & Thomas A. Baillie. (1979). The analysis of terbutaline in biological fluids by gas chromatography electron impact mass spectrometry. Journal of Mass Spectrometry. 6(1). 31–37. 24 indexed citations
9.
Draffan, G. H., et al.. (1977). Quantitative determination of the herbicide paraquat in human plasma by gas chromatographic and mass spectrometric methods. Journal of Chromatography A. 139(2). 311–320. 59 indexed citations
10.
Dollery, C. T., D. S. Davies, G. H. Draffan, et al.. (1976). Clinical pharmacology and pharmacokinetics of clonidine. Clinical Pharmacology & Therapeutics. 19(1). 11–17. 207 indexed citations
11.
Brash, Alan, Thomas A. Baillie, R. A. Clare, & G. H. Draffan. (1976). Quantitative determination of the major metabolite of prostaglandins F1α and F2α in human urine by stable isotope dilution and combined gas chromatography-mass spectrometry. Biochemical Medicine. 16(1). 77–94. 31 indexed citations
12.
Brash, Alan, G. H. Draffan, R. A. Clare, & Thomas A. Baillie. (1976). A New Method for the Determination of the Major Metabolite of Prostaglandin F2α in Human Urine Based on Stable Isotope Dilution and Gas Chromatography-Mass Spectrometry. Biochemical Society Transactions. 4(4). 706–708. 4 indexed citations
13.
Draffan, G. H., C T Dollery, D. S. Davies, et al.. (1976). Maternal and neonatal elimination of amobarbital after treatment of the mother with barbiturates during late pregnancy. Clinical Pharmacology & Therapeutics. 19(3). 271–275. 9 indexed citations
14.
Draffan, G. H., C. T. Dollery, Frances M. K. Williams, & R. A. Clare. (1974). Alveolar gas concentrations of fluorocarbons-11 and -12 in man after use of pressurized aerosols. Thorax. 29(1). 95–98. 5 indexed citations
15.
Grove, Jeffrey, P. A. Toseland, G. H. Draffan, R. A. Clare, & Faith M. Williams. (1974). Butobarbitone metabolism in man: identification of 3î-ketobutobarbitone. Journal of Pharmacy and Pharmacology. 26(3). 175–178. 7 indexed citations
16.
Draffan, G. H., et al.. (1973). Elimination kinetics of amobarbital in mothers and their newborn infants. Clinical Pharmacology & Therapeutics. 14(3). 442–447. 25 indexed citations
17.
Draffan, G. H., R. A. Clare, & Faith M. Williams. (1973). Determination of barbiturates and their metabolites in small plasma samples by gas chromatography-mass spectrometry. Journal of Chromatography A. 75(1). 45–53. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026